Michael J. Meaney is James McGill Professor of Medicine at Douglas Hospital Research Centre of McGill University. He is the Director of the Maternal Adversity, Vulnerability and Neurodevelopment Project and of the Developmental Neuroendocrinology Laboratory of McGill University. Dr. Meaney was educated at Loyola College of Montreal and received his PhD from Concordia University (Montreal) with post-doctoral training at The Rockefeller University in New York. Over this period Dr. Meaney’s primary research interest was on the effects of early experience on gene expression and development.
His research is multidisciplinary and includes studies of behaviour and physiology, to molecular biology and genetics. The primary objective of these studies is to define the processes that govern gene environment interactions. He has authored over 225 journal articles and has been the recipient of a Scientist Award from the Canadian Institutes for Health Research (CIHR) and a Distinguished Scientist Award from the National Alliance for Research in Schizophrenia and Affective Disorders. He currently holds a CIHR Senior Scientist Award. Graduates from Dr. Meaney’s lab hold faculty appointments across North America and Europe, including Queen’s University, University of California at Berkeley, University of British Columbia, University of Michigan, and the RIKEN Institute. Research in the Meaney lab is funded by grants from Canadian, American and Japanese agencies.